Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

The DexCom Stock Turnaround Is Showing Real Signs of Life

  • DexCom (DXCM) shares have put together an encouraging short-term bounce as the company maps out a multi-year growth algorithm.
  • The stock currently carries a 8% “Sell” rating, but that’s up from the prior day’s 96% “Sell” rating and 100% “Sell” last week. A positive trend on that indicator.
  • DXCM is building near-term upside strength, following its 2026 Investor Day strategy presentation last week.
  • Despite a steep winter drawdown that left the stock more than 50% below its 2024 high, and about 60% below its 2021 all-time high, a constructive base is forming well above its $56 multi-year low.

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.